Husni M. Elbahesh, Ph.D.
Affiliations: | 2011 | Georgia State University, Atlanta, GA, United States |
Area:
Virology Biology, Molecular Biology, Cell BiologyGoogle:
"Husni Elbahesh"Parents
Sign in to add mentor| Margo A. Brinton | grad student | 2011 | Georgia State | |
| (Study of intracellular innate immune response components in West Nile virus infected cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Meineke R, Stelz S, Busch M, et al. (2023) FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants. Iscience. 26: 106309 |
| Meineke R, Stelz S, Busch M, et al. (2022) FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections. Viruses. 14 |
| Di H, Elbahesh H, Brinton MA. (2020) Characteristics of Human OAS1 Isoform Proteins. Viruses. 12 |
| Jansen JM, Gerlach T, Elbahesh H, et al. (2019) Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination Journal of Clinical Virology. 119: 44-52 |
| Yang D, Li NL, Wei D, et al. (2019) The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function. Plos Neglected Tropical Diseases. 13: e0007537 |
| Bergmann S, Elbahesh H. (2019) Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses. Virology. 534: 54-63 |
| Elbahesh H, Gerlach T, Saletti G, et al. (2019) Response Modifiers: Tweaking the Immune Response Against Influenza A Virus. Frontiers in Immunology. 10: 809 |
| Meineke R, Rimmelzwaan GF, Elbahesh H. (2019) Influenza Virus Infections and Cellular Kinases Viruses. 11: 171 |
| Gerlach T, Elbahesh H, Saletti G, et al. (2019) Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines. 18: 379-392 |
| Elbahesh H, Saletti G, Gerlach T, et al. (2019) Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology. 34: 1-9 |